Altered expression of epidermal growth factor receptor in non-involved tissue of cancer-containing breasts

Breast

Volumn 10, Issue 4, 2001, Pages 318-324

  Hassan, H I ^a   Walker, R A ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIGOXIGENIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; MESSENGER RNA;

ADULT; AGED; ARTICLE; BASEMENT MEMBRANE; BASOLATERAL MEMBRANE; BREAST; BREAST CANCER; BREAST DUCT; CELL FUNCTION; CHEMICAL LABELING; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; FROZEN SECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MYOEPITHELIUM CELL; OLIGONUCLEOTIDE PROBE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING;

EID: 0034926960     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1054/brst.2000.0248     Document Type: Article

References (30)

1. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions
2. The prevalence of carcinoma in-situ in normal and cancer associated breasts
3. Cancerous versus non-cancerous breasts. A comparative morphological analysis of the entire glandular tree of the breast
4. Risk factors for breast cancer in women with proliferative breast disease
5. Anatomic markers of human premalignancy and risk of breast cancer
6. Reduction in apoptosis relative to mitosis in histologically normal epithelium accompanies fibrocystic change and carcinoma of the premenopausal human breast
7. Decreased apoptosis in non-involved tissue from cancer-containing breasts
8. Alteration of integrin and stromal protein expression-a marker of pre-malignant change in breast
9. Oestrogen receptor, epidermal growth factor receptor and oncoprotein expression in non-involved tissue of cancerous breasts
10. Cyclical activity and 'aging' of the human breast: Clues to assessment of risk and strategies for prevention
11. Lack of cyclin E immunoreactivity in non-malignant breast and association with proliferation in breast cancer
12. Expression of the transforming growth factor-alpha/epidermal growth factor receptor pathway in normal human breast epithelial cells
13. Epidermal growth factor receptors and oestrogen receptors in the non-malignant part of the cancerous breast
14. Differential expression of oestrogen, progesterone and epidermal growth factor receptors in normal, benign, and malignant human breast tissues using dual staining immunohistochemistry
15. Epidermal growth factor receptor and c-erbB-2 expression in normal breast tissue during the menstrual cycle
16. Epidermal growth factor receptor in human breast cancer
17. DNA flow cytometry of human breast carcinomas and its relationship to transferrin and epidermal growth factor receptors
18. Epidermal growth factor receptor expression in breast cancer: Association with responses to endocrine therapy
19. A monoclonal antibody to the human epidermal growth factor receptor
20. Expression of epidermal growth factor receptor mRNA and protein in primary breast carcinomas
21. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermal carcinoma cells
22. A "quickscore" method for immunohistochemical semiquantitation: Validation for oestrogen receptor in breast carcinomas
23. Expression of epidermal growth factor receptor in benign and malignant primary tumours of the breast
24. Neu oncogene and epidermal growth factor receptor are independently expressed in benign and malignant tissues
25. Growth factor expression in normal, benign and malignant breast tissue
26. Antisense estrogen receptor RNA expression increases epidermal growth factor receptor gene expression in breast cancer cells
27. Epidermal growth factor receptors: Critical mediators of multiple receptor pathways
28. Regulation of tyrosine kinase cascades by G-protein-coupled receptors
29. Employment of epidermal growth factor receptor in growth factor-independent signaling pathways
30. Characterization of human epidermal growth factor receptor and c-Src in human breast tumor cells